Canada Markets close in 3 hrs

Zymeworks Inc. (ZYME.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
33.10+0.53 (+1.63%)
As of 02:58PM EST. Market open.
Full screen
Loading interactive chart...
  • Business Wire

    Zymeworks Announces Pricing of $100.0 Million Public Offering

    VANCOUVER, British Columbia & SEATTLE, January 27, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the pricing of its underwritten public offering of 9,160,000 common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to 3,340,000 common shares. The common shares are being offered at a public offering price of $8.00 per common share and the pre-funded warrants are

  • Business Wire

    Zymeworks Announces Proposed Public Offering

    VANCOUVER, British Columbia & SEATTLE, January 26, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that it has commenced an underwritten public offering of its common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase its common shares. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may

  • Business Wire

    Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2022

    VANCOUVER, British Columbia & SEATTLE, January 19, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today provided a corporate update on its key strategic priorities for 2022 and 2023 in addition to confirming its upcoming clinical development milestones for zanidatamab and ZW49.